Alzheimer's disease (AD) is a chronic, progressive, neurodegenerative disorder that places
a substantial burden on patients, their families, and society. Alzheimer's disease (AD) is the …

To date, no truly efficacious drugs for Alzheimer's disease (AD) have been developed;
moreover, all new anti-AD drugs developed since 2003 have failed. To succeed where …

Alzheimer's disease (AD) is the most common cause of dementia worldwide. The etiology is
multifactorial, and pathophysiology of the disease is complex. Data indicate an exponential …

Alzheimer disease (AD) is the most common cause of dementia and is characterized by the
aggregation and accumulation of two proteins in the brain, amyloid‐β (Aβ) and tau. Aβ and …

Alzheimer's disease (AD) and other dementias represent a significant and increasing clinical
challenge. This review highlights current treatment options for AD and the main focusses of …

Alzheimer's disease (AD) is characterized by the abnormal extracellular accumulation of
amyloid β-peptide (Aβ) into neuritic plaques and the intraneuronal aggregation of the …

Alzheimer disease (AD) is the most common neurodegenerative disease and typically
affects patients older than age 65. Around this age, the number of neurons begins to …

Alzheimer's disease (AD) is a complex, progressive neurological disorder affecting elderly
population of above 65 years of age, characterized by failure of memory, loss of acquired …

Alzheimer's disease (AD) is a progressive neurodegenerative disorder that currently has no
cure. The aged population is growing globally, creating an urgent need for more promising …

Alzheimer's disease (AD) is a progressive neurodegenerative disease, involving a large
number of genes, proteins and their complex interactions. Currently, no effective therapeutic …